What is Inogen's EBITDA?

Inogen (INGN) reported EBITDA of -$4.43M in Q1 2026.

How has Inogen's EBITDA changed year-over-year?

Inogen's EBITDA decreased by 79.7% year-over-year, from -$2.47M to -$4.43M.

What is the long-term trend for Inogen's EBITDA?

Over 3 years (2022 to 2025), Inogen's EBITDA has grown at a -46.3% compound annual growth rate (CAGR), from -$61.73M to -$9.55M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Inogen INGN EBITDA

EBITDA at other companies

AdaptHealthAHCO

$111.96M-4.7%

Viemed Healthcare, Inc.VMD

$11.92M+14.0%

Pulmonx CorporationLUNG

-$12.74M+10.8%

SavaraSVRA

-$38.97M-37.2%

Tactile Systems TechnologyTCMD

$105K+104%

iRhythm Holdings, Inc. IRTC

-$11.14M+59.3%

Other financials

Income statement

See full

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

See full

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

See full

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation

See full

Market cap$174.63M-7.6%

Enterprise value$98.45M-5.8%

P/S0.5×-0.1×

Profitability

See full

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

FCF margin0.4%—

Returns & leverage

See full

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Where this comes from

Calculated from Inogen’s reported figures.

−$9.3Mebit+

$4.9MDepreciation Depletion & Amortization

=-$4.43M

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inogen's EBITDA?: Inogen (INGN) reported EBITDA of -$4.43M in Q1 2026.
How has Inogen's EBITDA changed year-over-year?: Inogen's EBITDA decreased by 79.7% year-over-year, from -$2.47M to -$4.43M.
What is the long-term trend for Inogen's EBITDA?: Over 3 years (2022 to 2025), Inogen's EBITDA has grown at a -46.3% compound annual growth rate (CAGR), from -$61.73M to -$9.55M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.